Journal article
Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.
- Abstract:
-
Aspirin has been a commercial drug for over a century, although for most of this history, an understanding of its mechanism of action, as an inhibitor of cyclooxygenase (COX) activity and thus of prostanoid synthesis, was lacking. Over the past fifty years, a large number of other nonsteroidal antiinflammatory drugs (NSAIDs) have been developed, and a much deeper understanding of inflammation and prostanoid action has emerged. Indeed, a new class of selective inhibitors of the cyclooxygenase-...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Molecular interventions
- Volume:
- 9
- Issue:
- 1
- Pages:
- 31-39
- Publication date:
- 2009-02-01
- DOI:
- EISSN:
-
1543-2548
- ISSN:
-
1534-0384
- Source identifiers:
-
49485
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:49485
- UUID:
-
uuid:fa04c388-b1a9-4e0e-98c7-f4524e54af14
- Local pid:
- pubs:49485
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2009
If you are the owner of this record, you can report an update to it here: Report update to this record